<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635412</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-13-1619</org_study_id>
    <nct_id>NCT02635412</nct_id>
  </id_info>
  <brief_title>Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial</brief_title>
  <acronym>MAP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial to investigate the optimal timing of delivery in
      clinically stable women with a suspected morbidly adherent placenta.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial to investigate the optimal timing of delivery in
      clinically stable women with a suspected morbidly adherent placenta dispositioned for a
      scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal
      morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36
      weeks gestational age).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2016</start_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite neonatal morbidity</measure>
    <time_frame>Within 72 hours of newborn discharge</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal neonatal morbidity</measure>
    <time_frame>Within 72 hours of patient discharge</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Morbidly Adherent Placenta</condition>
  <condition>Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>Scheduled delivery at 34 weeks</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Scheduled delivery at 34 weeks (range 33 weeks 5 days to 34 weeks 3 days)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scheduled delivery at 36 weeks</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Scheduled delivery at 36 weeks (range 35 weeks 5 days to 36 weeks 3 days)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Scheduled timing of delivery</intervention_name>
    <arm_group_label>Scheduled delivery at 34 weeks</arm_group_label>
    <arm_group_label>Scheduled delivery at 36 weeks</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with monographically morbidly adherent placenta with or without a placenta
             previa.

          -  Scheduled delivery via cesarean hysterectomy

        Exclusion Criteria:

          -  Delivery planned prior to 36 weeks (e.g. non-reassuring fetal status, preterm labor,
             severe preeclampsia, other medical/fetal indication for delivery as determined by the
             managing physician).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Robyn P Roberts, MD</last_name>
    <phone>734-934-4227</phone>
    <email>robyn.p.roberts@uth.tmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maria Hutchinson, MS</last_name>
    <phone>713-500-5850</phone>
    <email>maria.s.keefer@uth.tmc.edu</email>
  </overall_contact_backup>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2015</study_first_submitted>
  <study_first_submitted_qc>December 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2015</study_first_posted>
  <last_update_submitted>February 11, 2016</last_update_submitted>
  <last_update_submitted_qc>February 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Robyn Roberts</investigator_full_name>
    <investigator_title>Fellow</investigator_title>
  </responsible_party>
  <keyword>Placenta</keyword>
  <keyword>Accreta</keyword>
  <keyword>Morbidly</keyword>
  <keyword>Adherent Placenta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

